Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001104659-19-002543

Chief Technology Officer sold 7,000 shares at an average $26.36 ($184,540)

  • Chief Technology Officer acquired 7,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myer Vickesh · Chief Technology Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-17 Exercise or conversion : show line 1 in the form +3,000 $0.65 $1,950 3,000 D
2019-01-17 Sale : show line 2 in the form −3,000 $26.18 $78,540 0 D
2019-01-18 Exercise or conversion : show line 3 in the form +4,000 $11.21 $44,840 4,000 D
2019-01-18 Sale : show line 4 in the form −4,000 $26.50 $106,000 0 D
Open-market sales · 7,000 sh · avg $26.36 · $184,540

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-01-17 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −3,000 79,307 D
2019-01-18 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −4,000 52,897 D
Loading xslF345X03/a4.xml…